| Schedule of Computation of Basic and Diluted Earnings Per Share |
The following table illustrates the computation of basic and diluted earnings per share (in thousands, except share and per share amounts): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | | Numerator | | | | | | | | | | Net (loss) income attributable to Sabra Health Care REIT, Inc. | | $ | (25,202) | | | $ | 65,542 | | | $ | 15,678 | | | $ | 105,846 | | | Denominator | | | | | | | | | | Basic weighted average common shares and common equivalents | | 252,268,939 | | | 237,976,314 | | | 252,202,390 | | | 237,933,910 | | | Dilutive restricted stock units | | — | | | 2,755,911 | | | 2,524,248 | | | 2,671,820 | | | Dilutive forward equity sale agreements | | — | | | 197,641 | | | 1,028,859 | | | 105,657 | | | Diluted weighted average common shares | | 252,268,939 | | | 240,929,866 | | | 255,755,497 | | | 240,711,387 | | | Net (loss) income attributable to Sabra Health Care REIT, Inc., per: | | | | | | | | Basic common share | | $ | (0.10) | | | $ | 0.28 | | | $ | 0.06 | | | $ | 0.44 | | | Diluted common share | | $ | (0.10) | | | $ | 0.27 | | | $ | 0.06 | | | $ | 0.44 | |
|